These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 1374229)
1. [Advances in the fundamentals and therapeutic use of immunosuppressive agents]. Ochiai T Arerugi; 1992 Mar; 41(3):381-4. PubMed ID: 1374229 [No Abstract] [Full Text] [Related]
5. Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols. Lang P; Baron C Nephrol Dial Transplant; 1997 Oct; 12(10):2050-4. PubMed ID: 9351062 [No Abstract] [Full Text] [Related]
6. Clinical and experimental immunosuppression. Castillo Lugo JA Bol Asoc Med P R; 1995; 87(5-6):106-8. PubMed ID: 8573248 [No Abstract] [Full Text] [Related]
7. [Immunosuppressive agents--advances of the developmental studies and the mode of action]. Ochiai T; Isono K; Gunji Y; Nagata M Nihon Rinsho; 1991 Jun; 49(6):1436-41. PubMed ID: 1715926 [No Abstract] [Full Text] [Related]
8. New immunosuppressive agents for organ transplantation. Waer M Acta Clin Belg; 1997; 52(4):199-203. PubMed ID: 9351290 [No Abstract] [Full Text] [Related]
9. New horizons in immunosuppression. Simmons RL; Wang SC Transplant Proc; 1991 Aug; 23(4):2152-6. PubMed ID: 1714645 [No Abstract] [Full Text] [Related]
10. Advances in immunosuppression for heart transplantation. Kobashigawa JA Adv Card Surg; 1998; 10():155-74. PubMed ID: 9917904 [No Abstract] [Full Text] [Related]
11. Immunosuppressive agents: recent developments in molecular action and clinical application. Gerber DA; Bonham CA; Thomson AW Transplant Proc; 1998 Jun; 30(4):1573-9. PubMed ID: 9636637 [No Abstract] [Full Text] [Related]
12. Immunosuppressive approaches to the prevention of graft vascular disease. Gregory CR Transplant Proc; 1998 May; 30(3):878-80. PubMed ID: 9595134 [No Abstract] [Full Text] [Related]
14. New antirejection drugs anticipated. Randall T JAMA; 1990 Sep; 264(10):1225. PubMed ID: 1696999 [No Abstract] [Full Text] [Related]
15. Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival. Wang J; Morris RE Transplant Proc; 1991 Feb; 23(1 Pt 1):699-702. PubMed ID: 1990655 [No Abstract] [Full Text] [Related]
16. Efficacy of rapamycin, RS-61443, and cyclophosphamide in the prolongation of survival of discordant pig-to-rabbit cardiac xenografts. Yatscoff RW; Wang S; Keenan R; Chackowsky P; Koshal A Transplant Proc; 1994 Jun; 26(3):1271-3. PubMed ID: 8029905 [No Abstract] [Full Text] [Related]
17. New small molecule immunosuppressants for transplantation: review of essential concepts. Morris RE J Heart Lung Transplant; 1993; 12(6 Pt 2):S275-86. PubMed ID: 7508752 [TBL] [Abstract][Full Text] [Related]
18. Quality assessment issues of new immunosuppressive drugs and experimental experience. Holt DW; Jones K; Lee T; Stadler P; Johnston A Ther Drug Monit; 1996 Aug; 18(4):362-7. PubMed ID: 8857551 [TBL] [Abstract][Full Text] [Related]
19. New immunosuppressive agents. Bumgardner GL; Roberts JP Gastroenterol Clin North Am; 1993 Jun; 22(2):421-49. PubMed ID: 7685324 [TBL] [Abstract][Full Text] [Related]
20. How to use mTOR inhibitors? The search goes on. Budde K Am J Transplant; 2011 Aug; 11(8):1551-2. PubMed ID: 21668636 [No Abstract] [Full Text] [Related] [Next] [New Search]